News Daily News CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR Todd Neale December 30, 2020
News Daily News Patient Complexity Increasing at PCI Sites Without Surgical Backup Yael L. Maxwell December 29, 2020
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020
News Industry News MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions. December 16, 2020
News Conference News ‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III Shelley Wood November 19, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Industry News Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt November 17, 2020
News Conference News AHA 2020 FIDELIO-DKD: Finerenone Cuts CV Events in Diabetic Kidney Disease Todd Neale November 16, 2020
News Conference News AHA 2020 EARLY-AF: First-line Ablation Beats Meds for Recent Paroxysmal A-fib Shelley Wood November 16, 2020
News Conference News AHA 2020 Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT Shelley Wood November 15, 2020
News Conference News AHA 2020 OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients Todd Neale November 15, 2020
News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Daily News Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut Michael O'Riordan October 28, 2020
News Industry News Medtronic Venous Stent Recieves U.S. FDA Approval to Treat Venous Outflow Obstruction October 26, 2020
News Conference News TCT 2020 Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT Todd Neale October 21, 2020
News Conference News TCT 2020 IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs L.A. McKeown October 18, 2020
News Industry News CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI October 17, 2020